Primary Site >> Colorectal Cancer

Gene >> ACTG1

Journal: Expert Rev Anticancer Ther. 2014 Dec;14(12):1477-93.
Title: Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.
Author: Price, Timothy J|Segelov, Eva|Burge, Matthew|Haller, Daniel G|Tebbutt, Niall C|Karapetis, Christos S|Punt, Cornelis J A|Pavlakis, Nick|Arnold, Dirk|Gibbs, Peter|Shapiro, Jeremy D
PMID: 25138900
Journal: Expert Rev Anticancer Ther. 2016 May;16(5):557-71.
Title: Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.
Author: Price, Timothy J|Thavaneswaran, Subotheni|Burge, Matthew|Segelov, Eva|Haller, Daniel G|Punt, Cornelis Ja|Arnold, Dirk|Karapetis, Christos S|Tebbutt, Niall C|Pavlakis, Nick|Gibbs, Peter|Shapiro, Jeremy D
PMID: 27010906
Journal: Cell Death Dis. 2017 Apr 6;8(4):e2739.
Title: miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis.
Author: Liu, Yankun|Zhang, Yingnan|Wu, Haidong|Li, Yufeng|Zhang, Yi|Liu, Min|Li, Xin|Tang, Hua
PMID: 28383561